Maynard Um
-
-
-
-
-
-
-
Zai Lab Limited (ZLAB) Misses Q3 EPS by 8c
-
-
-
-
-
-
-
Zai Lab Limited (ZLAB) Announces Positive Topline Phase 3 Results for Bemarituzumab
-
-
-
-
-
-
-
Cantor Fitzgerald Reiterates Overweight Rating on Zai Lab (ZLAB)
-
-
-
-
-
-
-
Zai Lab Limited (ZLAB) Tops Q4 EPS by 65c ; Offers Guidance
-
-
-
-
-
-
-
Zai Lab Limited (ZLAB) Tops Q3 EPS by 73c
-
-
-
-
-
-
-
Zai Lab (ZLAB) -Supported Study Published in Cell Provides New Insights with Potential to Improve Treatment of HRD-Positive Ovarian Cancers
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

